↓ Skip to main content

Cochrane Database of Systematic Reviews

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

Overview of attention for article published in Cochrane database of systematic reviews, November 2014
Altmetric Badge

Mentioned by

twitter
1 tweeter
facebook
1 Facebook page

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
173 Mendeley
citeulike
1 CiteULike
Title
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy
Published in
Cochrane database of systematic reviews, November 2014
DOI 10.1002/14651858.cd008721.pub2
Pubmed ID
Authors

Maria José Martinez-Zapata, Arturo J Martí-Carvajal, Ivan Solà, José I Pijoán, José A Buil-Calvo, Josep A Cordero, Jennifer R Evans

Abstract

Proliferative diabetic retinopathy (PDR) is a complication of diabetic retinopathy that can cause blindness. Although panretinal photocoagulation (PRP) is the treatment of choice for PDR, it has secondary effects that can affect vision. An alternative treatment such as anti-vascular endothelial growth factor (anti-VEGF), which produces an inhibition of vascular proliferation, could improve the vision of people with PDR.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 173 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 <1%
United Kingdom 1 <1%
China 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 168 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 17%
Researcher 25 14%
Student > Bachelor 19 11%
Student > Ph. D. Student 17 10%
Other 13 8%
Other 35 20%
Unknown 34 20%
Readers by discipline Count As %
Medicine and Dentistry 84 49%
Nursing and Health Professions 14 8%
Agricultural and Biological Sciences 5 3%
Biochemistry, Genetics and Molecular Biology 5 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Other 21 12%
Unknown 39 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 December 2014.
All research outputs
#15,064,404
of 18,812,327 outputs
Outputs from Cochrane database of systematic reviews
#10,936
of 11,864 outputs
Outputs of similar age
#201,039
of 286,760 outputs
Outputs of similar age from Cochrane database of systematic reviews
#238
of 246 outputs
Altmetric has tracked 18,812,327 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,864 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.6. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,760 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 246 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.